Sevsury

surufatinib · Hutchmed Europe B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sevsury, covering 2022-11-16 to 2022-11-16. Get the full timeline:

Most recent: EMA Application withdrawn: Sevsury (surufatinib) — Hutchmed Europe B.V.